Opaleye Management Inc.

10% OwnerProtara Therapeutics, Inc. (TARA) · full profile →Form 4 · filed Jun 28, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$143K
Net Open-Market Flow
-$143K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 28, 2024Sell(S)13K$2.07$27K2.2M
Jun 28, 2024Sell(S)5K$2.07$10K85K
Jun 27, 2024Sell(S)12K$2.26$28K90K
Jun 27, 2024Sell(S)34K$2.26$77K2.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-025666) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about TARA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001493152-24-025666"
Ask your agent
Use Arkolith to summarize insider buying and selling at Protara Therapeutics, Inc.
over the last 90 days and cite the filings.